Immunome

(NASDAQ) IMNM

Current Price$18.75

Market Cap$2.12B

Since IPO (2020)+39%

5 Year+13%

1 Year+112%

1 Month-5%

Immunome Financials at a Glance

Market Cap

$2.12B

Revenue (TTM)

$4.02M

Net Income (TTM)

-$224.59M

EPS (TTM)

-$2.38

P/E Ratio

-7.88

Dividend

$0.00

Beta (Volatility)

1.53 (High)

Dividend

$0.00

Beta (Volatility)

1.53 (High)

Price

$18.75

Volume

3,318,517

Open

$18.79

Price

$18.75

Volume

3,318,517

Open

$18.79

Previous Close

$18.74

Daily Range

$18.04 - $19.15

52-Week Range

$7.96 - $27.65

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.53 (High)

Price

$18.75

Volume

3,318,517

Open

$18.79

Previous Close

$18.74

Daily Range

$18.04 - $19.15

52-Week Range

$7.96 - $27.65

Estimated Earnings Date

Aug 6, 2026

IMNM News

Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More

Seena HassounaApr 4, 2026

Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing

Jake LerchMar 4, 2026

IMNM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immunome

Industry

Biotechnology

Sector

Health Care

Employees

177

CEO

Clay B. Siegall, PhD

Website

www.immunome.com

Headquarters

Bothell, PA 19341, US

IMNM Financials

Key Financial Metrics (TTM)

Gross Margin

-12%

Operating Margin

-59%

Net Income Margin

-56%

Return on Equity

-50%

Return on Capital

-40%

Return on Assets

-36%

Earnings Yield

-12.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.12B

Shares Outstanding

113.25M

Volume

3.32M

Avg. Volume

1.27M

Financials (TTM)

Gross Profit

$3.99M

Operating Income

-$214.11M

EBITDA

-$209.44M

Operating Cash Flow

-$190.92M

Capital Expenditure

-$9.69M

Free Cash Flow

-$200.60M

Cash & ST Invst.

$653.48M

Total Debt

$3.86M

Immunome Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$753.00K

-125.7%

Gross Margin

0.00%

N/A

Market Cap

$2.12B

N/A

Market Cap/Employee

$16.20M

N/A

Employees

131

N/A

Net Income

-$53.84M

-29.3%

EBITDA

-$53.09M

-29.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$582.69M

+83.6%

Total Debt

$3.69M

-22.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$3.69M

-22.6%

Short Term Debt

$0.00

N/A

Return on Assets

-36.24%

N/A

Return on Invested Capital

-40.31%

N/A

Free Cash Flow

-$61.64M

-8.7%

Operating Cash Flow

-$58.64M

-10.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CLDXCelldex Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.$32.43-1.52%

PHVSPharvaris N.V.

PHVSPharvaris N.V.$32.80-1.83%

NTLAIntellia Therapeutics, Inc.

NTLAIntellia Therapeutics, Inc.$15.67+3.09%

VERAVera Therapeutics, Inc.

VERAVera Therapeutics, Inc.$35.09+0.23%

ABCLAbCellera Biologics Inc.

ABCLAbCellera Biologics Inc.$5.53+1.65%

BHVNBiohaven Ltd.

BHVNBiohaven Ltd.$13.57-0.37%

MAZEMaze Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.$25.68+3.38%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.49-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.99+0.04%

PFEPfizer

PFEPfizer$25.21-0.03%

AAPLApple

AAPLApple$298.01+0.01%

QSQuantumScape

QSQuantumScape$8.04+0.17%

SOFISoFi Technologies

SOFISoFi Technologies$17.91+0.03%

FLEXFlex

FLEXFlex$147.61+0.03%

Questions About IMNM

What is the current price of Immunome?

Immunome is trading at $18.74 per share.

What is the 52-week range for Immunome?

Over the past 52 weeks, Immunome has traded between $7.96 and $27.65.

How much debt does Immunome have?

As of the most recent reporting period, Immunome reported total debt of $3.69M.

How much cash does Immunome have on hand?

Immunome reported $582.69M in cash and cash equivalents in its most recent financial results.

What is Immunome’s dividend yield?

Immunome does not currently have a dividend yield.

Immunome

Immunome Financials at a Glance

IMNM News

Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More

Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing

Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120%

Why Immunome Stock Surged Today

Immunome (IMNM) Q2 Revenue Surges 382%

IMNM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Immunome

IMNM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Immunome Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMNM

What is the current price of Immunome?

What is the 52-week range for Immunome?

How much debt does Immunome have?

How much cash does Immunome have on hand?

What is Immunome’s dividend yield?

Premium Investing Services